Data from the pilot study, which included around 600 men, showed that 14 (3%) of the 422 participants who underwent PSA testing had prostate cancer.82 15–20% had hypertension and pre-diabetes (and 5% had overt diabetes). This evidence concerns the gene KLK3 and prostate cancer.